Results 221 to 230 of about 410,888 (293)

Global patterns and trends in kidney cancer incidence and mortality

International Journal of Cancer, EarlyView.
What's New? Decreasing mortality from kidney cancer in developed countries contrasts with persistently high or rising mortality in less‐developed regions. Factors underlying this widening gap remain incompletely understood. Using GLOBOCAN 2022 data, the present study examined patterns in kidney cancer incidence and mortality worldwide and the relation ...
Anton Barchuk, Jerome Vignat, Kari A. O. Tikkinen, Ahmedin Jemal, Freddie Bray, Ariana Znaor   +5 more
wiley   +1 more source

A cost‐effectiveness analysis of breast cancer treatment in certified versus non‐certified hospitals in Germany

International Journal of Cancer, EarlyView.
What's New? This study is the first to quantify the cost‐effectiveness of breast cancer treatment in German Cancer Society‐certified hospitals using real‐world data from over 140,000 patients. Analysis on certification‐related costs and survival outcomes demonstrates that high‐quality multidisciplinary care at certified hospitals delivers substantial ...
Min‐Wai Lwin, Olaf Schoffer, Christoph Streissnig, Pauline Wimberger, Michael Gerken, Veronika Bierbaum, Christoph Bobeth, Martin Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues‐van Tol, Theresa Link, Anton Scharl, Elisabeth C. Sturm‐Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt, Michael Schlander   +20 more
wiley   +1 more source

Impact of vitamin D non-reimbursement policy on therapy discontinuation in the general and rheumatic population in the Netherlands: a cross-sectional study. [PDF]

BMJ Open
Singh A, Huiskes VJB, van den Bemt BJF, van Ameijden H, Nurmohamed MT, Spijkers KM, Vervloet M, Brabers AEM.   +7 more
europepmc   +1 more source

Real‐world progression‐free survival and overall survival in patients with HR+/HER2− advanced breast cancer treated in first‐line with ribociclib, endocrine monotherapy or chemotherapy: Results from the observational RIBANNA study

International Journal of Cancer, EarlyView.
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching, Cosima Brucker, Thomas Decker, Anne Engel, Thomas Göhler, Christian Jackisch, Jan Janssen, Andreas Köhler, Kerstin Lüdtke‐Heckenkamp, Diana Lüftner, Frederik Marmé, Marion van Mackelenbergh, Beate Rautenberg, Marcus Schmidt, Rudolf Weide, Pauline Wimberger, Elena Kisseleff, Christina Pfister, Claudia Quiering, Christian Roos, Achim Wöckel   +20 more
wiley   +1 more source

Economic Evaluation of GARDE: A Digital Health Platform for Population-Level Hereditary Cancer Risk Assessment. [PDF]

JCO Oncol Pract
Ahsan MD, Kaphingst KA, Kohlmann WK, Bradshaw RL, Allen CG, Schlechter C, Kukhareva P, Maxwell W, Martin C, Davis-Rivera L, Madeo AC, Borsato EP, Frey MK, Kawamoto K, Fiol GD, Elkin EB, Sharaf RN.   +16 more
europepmc   +1 more source

Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women

International Journal of Cancer, EarlyView.
What's New? This population‐based cohort study aimed to demonstrate how annual audits of all aspects of the cervical cancer screening pathway can be performed using register national data with clinical validation to identify patterns of risk and inform program change.
Cecilia Kärrberg, Penelope Gray, Kristina Elfgren, Hanna Milerad, Bengt Andrae, Jiayao Lei, Pär Sparén, Joakim Dillner, Jiangrong Wang, K. Miriam Elfström   +9 more
wiley   +1 more source

Mind the gap: a German case study on the discrepancy between geographic accessibility and real-world utilization of botulinum toxin therapy. [PDF]

Front Neurol
Koelsche T, Jansen R, Masanneck L, Pawlitzki M, Meuth SG, Lee JI, Albrecht P.   +6 more
europepmc   +1 more source

Treatment patterns and clinical outcomes in real‐world patients with small‐cell lung cancer in South Korea: A single‐center experience

International Journal of Cancer, EarlyView.
What's New? The emerging role of immunotherapy in small‐cell lung cancer treatment has not been fully elucidated, particularly outside of clinical trials. This single‐center retrospective cohort study examined real‐world treatment patterns and overall survival in South Korea during the 2018–2023 period.
Sehhoon Park, Danbee Kang, Jin Lee, Hyun Ae Jung, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Hojoon Lee, Hyuna Lim, Xerxes Pundole, Juhee Cho, Myung‐Ju Ahn   +11 more
wiley   +1 more source

Examining Medicare Reimbursement Differences for Cochlear Implant Surgery. [PDF]

Cureus
Ali L, Salib S, Hazzard I, Howard J, Ostroot C, Salem A, Isaacs RS.   +6 more
europepmc   +1 more source

Communication Access Funds: Achieving the Unrealized Aims of the Americans with Disabilities Act [PDF]

, 2011
Rosenblum, Howard A.
core   +1 more source